163 - Hypoglycemia
نویسنده
چکیده
Patients who use insulin or oral hypoglycemic medications are at the greatest risk for hypoglycemia. These patients experience mild, self-treated hypoglycemic episodes about twice per week. Severe hypoglycemia, which requires the assistance of another person to regain euglycemia, is experienced at least once per year by 27% of patients treated with intensive insulin regimens. Hypoglycemia is the cause of death in approximately 3% of people with insulin-dependent diabetes. Patients taking oral hypoglycemic agents also commonly experience hypoglycemia. Although these episodes are generally associated with milder symptoms, they occur in more than 30% of patients each year. Sulfonylureas are the most widely used oral hypoglycemic agents. In 2004, 4148 sulfonylurea overdoses were reported to American poison control centers; of these, 36% occurred in children younger than 6 years, 21% required treatment of hypoglycemia, 2.5% were lifethreatening, and 0.22% were fatal. The incidence of hypoglycemia is expected to rise as tight glycemic control continues to be emphasized for the 17 million Americans with diabetes. Hypoglycemia in nondiabetic patients is quite rare and should raise concern about the possibility of a severe underlying illness, alcohol ingestion, or inappropriate exposure to insulin or an oral hypoglycemic agent.
منابع مشابه
In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta
The synthetic nonapeptide VQGEESNDK, corresponding to the fragment 163-171 of human IL-1 beta, showed in vivo immunomodulatory capacities qualitatively and quantitatively comparable to those of the mature human IL-1 beta protein. In fact, both IL-1 beta and the 163-171 fragment stimulated the immune response of normal mice and restored immune reactivities of immunocompromised animals. In additi...
متن کاملCounterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.
Plasma counterregulatory hormones and symptoms were measured during hypoglycemia in the postprandial and in the fasting state in humans to establish differences in physiological responses. We studied 8 nondiabetic subjects and 10 subjects with type 1 diabetes on two different occasions during clamped insulin-induced hypoglycemia (2.4 mmol/l) in the sitting position. On one occasion, subjects at...
متن کاملThe influence of insulin on circulating ghrelin.
Ghrelin is a novel peptide that acts on the growth hormone (GH) secretagogue receptor in the pituitary and hypothalamus. It may function as a third physiological regulator of GH secretion, along with GH-releasing hormone and somatostatin. In addition to the action of ghrelin on the GH axis, it appears to have a role in the determination of energy homeostasis. Although feeding suppresses ghrelin...
متن کاملHypoglycemia-associated autonomic failure is prevented by opioid receptor blockade.
CONTEXT Repeated hypoglycemia is associated with hypoglycemia-associated autonomic failure (HAAF), a syndrome of defective counterregulation. OBJECTIVE HAAF increases the risk of severe hypoglycemia in diabetes, although its mechanism remains unresolved. Because beta-endorphin influences the autonomic response to hypoglycemia via opioid receptor activation, we hypothesized that it is also inv...
متن کاملAssociation of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.
References 1. Cox DJ, Gonder-Frederick LA, Clarke WL: Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes 42:239–243, 1993 2. Cox DJ, Gonder-Frederick LA, Kovatchev BP, Julian DM, Clarke WL: Driving impairment during progressive hypoglycemia: occurrence, awareness and correction. Diabetes Care 23:163–170, 2000 3. Cox DJ, Penberthy JK, Zrebiec J, Weinger K, Aikens J, Ste...
متن کامل